[ad_1]
The announcement of the efficacy of the vaccine developed by the American biotechnology company Moderna, estimated at 94.5%, sparked a wave of hope: the world is preparing for vaccination. In Europe, new restrictions are adopted to deal with the second wave; in France the curves show encouraging signs.
- The epidemic appears to be on the decline in France
The epidemic appears to be on the decline in France, where the curves of new hospital admissions are stabilizing. “If there are signs of improvement in terms of the epidemic, we have not yet defeated the virus”Health Minister Olivier Véran warned on Monday 16 November, urging his fellow citizens to do so “Don’t relax (their) efforts.” Public Health France’s daily report identifies 9,406 new positive cases for the coronavirus. The number of additional deaths in 24 hours, however, is 508 people on Monday.
- New hope with the Moderna vaccine
Following Pfizer / BioNTech last week, US biotech company Moderna announced Monday that its vaccine was 94.5 percent effective. This means that the risk of getting Covid-19 was reduced by 94.5% between the placebo group and the vaccinated group of the large ongoing clinical trial in the United States. In this case, 90 participants in the placebo group took Covid-19, compared with 5 in the vaccinated group.
SEE ALSO – Moderna laboratory offers 94.5% effective vaccine against Covid-19
- The United States hopes to vaccinate 20 million people in December
Pfizer / BioNtech and Moderna vaccines could be licensed by the United States Medicines Agency (FDA) in the first half of December, Moncef Slaoui, chief scientist of Operation Warp Speed responsible for vaccinating the American population, said Monday. This would allow 20 million Americans to be vaccinated, probably the most elderly and at risk as a priority, from the second half of December. In total, the United States estimates that with different vaccines there will be sufficient doses by early April for the entire population.
As for Europe, officials said vaccinations can begin in January, subject to approval.
- Free vaccine in Belgium
The Belgian government announced on Monday its intention to treat at least 70% of the country’s population, or 8 million people, with future vaccines against Covid-19, and to ensure they are free. “For every citizen”.
- Tightening of restrictions in Northern Europe
Scandinavian countries, hitherto adhering to a more flexible health protocol than that of their European neighbors, adopted new measures on Monday to tackle the second wave of coronavirus. Sweden announced on Monday that it would limit public meetings to a maximum of eight people, one first. In Norway, the municipality of Oslo has announced the tightening of the rules of “social confinement” for adolescents, particularly affected by a recent resumption of the epidemic.
TO SEE ALSO – Covid-19: Sweden bans meetings of more than 8 people
- Austria submerged by the second wave
Austria begins a second block on Tuesday, with the closure of non-essential schools and shops and a call to stay at home. The average number of daily contaminations on Monday was 809 per million population over the past seven days, much more than in the United States (460) or neighboring Germany (221).
- More than 1.3 million deaths worldwide
The Covid-19 pandemic has killed at least 1,319,561 people worldwide since December. The United States is the country with the most deaths with 247,116 deaths, ahead of Brazil (166,014), India (130,070), Mexico (98,542) and the United Kingdom (51,934).
- The sale of Christmas trees will soon be authorized
Christmas may be limited, but it will have its own tree. A decree will be published to authorize the sale of these Christmas trees “in the next days”Agriculture Minister Julien Denormandie said yesterday.
TO SEE ALSO – Covid-19: “The vaccine will not end the pandemic”, warns the WHO
.
[ad_2]
Source link
